Mohamad Haqiqian
PET Radiopharmacy Production & QC Analyst, Radiation Safety Supervisor Curium Pharma
Dr Mohamad Haqiqian is a radiopharmaceutical and radiation safety specialist at University College London Hospitals (UCLH) and Curium Pharmaceuticals, specialising in radiopharmaceutical manufacturing, development, radiation safety, and applied medical physics. He holds a PhD, MSc, and BSc in Nuclear Engineering and Medical Radiation Engineering. His research includes in vivo and in vitro studies investigating combination therapies integrating nanotechnology and radiation therapy for pancreatic cancer. He has extensive experience in GMP-compliant radiopharmaceutical manufacturing, quality assurance, radiation physics, dosimetry, and regulatory compliance. He actively contributes to radiation safety training, supporting innovation and operational excellence in nuclear medicine and targeted radiopharmaceuticals
Seminars
- Understanding how radiation safety requirements differ between diagnostic and therapeutic radiopharmaceuticals, particularly as longer-lived radionuclides enter clinical use
- Optimising manufacturing, QC and clinical workflows to reduce waste and maximise patient-ready doses
- Preparing sites to safely implement new radionuclides to support scalable clinical and commercial growth
